Table 6.
Characteristics of patients with failure
| Age at Diagnosis | Menopause Status | ASTRO Category | Size | Histology | Grade | Biomarker Pattern | Node Biopsy | Adjuvant Treatment | Radiation Modality | Initial Failure | Failure (months) | Salvage Treatment | Current Status |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 61.7 | Post | cautionary | 1.00 | DCIS | II | +/-/? | No | R + E | APBI | Local - E | 20.3 | MRM + C + E | NED |
| 62.1 | Post | acceptable | 0.30 | IDC | I | +/+/- | Yes | R + E | APBI | Local - T | 45.3 | MRM + C | NED |
| 66.8 | Post | acceptable | 1.00 | IDC | II | +/+/- | Yes | R + E | APBI | Local - E | 59.6 | SM | NED |
| 69.3 | Post | acceptable | 2.00 | IDC | II | +/-/- | Yes | R + E | APBI | Local - E | 38.2 | PM + C + WBI + E | NED |
| 59.5 | Post | cautionary | 2.00 | IDC | II | +/-/- | Yes | R + E + C | APBI | Local - E | 47.1 | MRM + C + E | NED |
| 68.2 | Post | cautionary | 0.90 | IDC | III | -/-/- | Yes | R | WBI | Local - E | 49.5 | MRM | NED |
| 57.0 | Post | cautionary | 1.50 | IDC | III | -/-/- | Yes | R + C | WBI | Local - T | 5.2 | SM | NED |
| 56.5 | Post | cautionary | 0.90 | DCIS | III | +/+/? | No | R | WBI | Local - T | 49.3 | SM | NED |
| 62.3 | Post | acceptable | 0.60 | IDC | II | +/+/- | Yes | R + E | WBI | Local - E | 97.5 | MRM + E | NED |
| 45.4 | Pre | unsuitable | 3.00 | IDC | II | +/+/- | Yes | R + E + C | APBI | Regional | 55.0 | SR + C | Expired |
| 53.6 | Post | cautionary | 3.00 | IDC | II | +/+/- | Yes | R + E | APBI | Regional | 17.1 | SR + C + R | NED |
| 70.7 | Post | cautionary | 0.80 | IDC | III | -/-/- | Yes | R | APBI | Metastatic | 32.4 | C + H | Expired |
| 68.6 | Post | cautionary | 1.00 | IDC | III | +/+/- | Yes | R | WBI | Metastatic | 13.2 | - | Expired |
| 71.1 | Post | cautionary | 2.10 | IDC | III | -/-/+ | Yes | R + C | APBI | Metastatic | 45.4 | C + R | Under Treatment |
| 56.5 | Post | cautionary | 2.90 | IDC | III | +/+/+ | Yes | R + C + E | APBI | Metastatic | 60.8 | R | Under Treatment |
| 58.1 | Post | cautionary | 1.50 | IDC | II | +/-/- | Yes | R | WBI | Metastatic | 46.1 | C | Under Treatment |
Abbreviations: SM simple mastectomy, MRM modified radical mastectomy, PM partial mastectomy, R radiotherapy, C chemotherapy, E endocrine therapy, H Herceptin, Local-T - true recurrence, Local-E - elsewhere recurrence. Biomarker pattern shows the status for estrogen receptor, progesterone receptor, and HER2/neu using the following symbolic code: (ER)/(PR)/(HER2/neu). Presence of the biomarker is indicated by '+,' absence by '-,' unknown by '?.'